$BSGM Operation Warp Speed lead Janet Woodcock just spoke with Meg Tirell , she was asked about antiviral development. Without naming names it sounds like they are well aware and following the mmpd trial. Watch the video response below. Other interesting tidbits form the interview. -Many people within the FDA believe antibody therapies will not be useful for hospitalized patients , only for those who are mild/moderate and immunocompromised - 94% of trials currently running for therapeutics will not produce actionable results for FDA , they are observational non randomized trials and many are underpowered and having trouble with recruitment. streamable.com/ayk0jj
  • 9
Jerry Zeldis has also previously confirmed that ViralClear is in touch with Operation Warp Speed at the highest levels.
  • 2
2 Likes